Usefulness of Mendelian randomization in observational epidemiology

International Journal of Environmental Research and Public Health

Volumn 7, Issue 3, 2010, Pages 711-728

  Bochud, Murielle ^a   Rousson, Valentin ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Causality; Genetic epidemiology; Instrumental variables; Observational studies

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALDEHYDE DEHYDROGENASE ISOENZYME 2; APOLIPOPROTEIN E; ARYLAMINE ACETYLTRANSFERASE; ARYLDIALKYLPHOSPHATASE 1; BETA CAROTENE 15,15' MONOOXYGENASE; C REACTIVE PROTEIN; CYTOCHROME P450 1A2; FIBRINOGEN; GLUTATHIONE TRANSFERASE A1; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 18; LACTASE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN RECEPTOR; MACROPHAGE MIGRATION INHIBITION FACTOR; RETINOL BINDING PROTEIN 4; SEX HORMONE BINDING GLOBULIN;

ALCOHOL CONSUMPTION; CARDIOVASCULAR DISEASE; CAUSAL ATTRIBUTION; DEPRESSION; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MATHEMATICAL MODEL; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OVARY POLYCYSTIC DISEASE; RANDOMIZATION; REVIEW; RISK FACTOR; SIMULATION; STILLBIRTH; ALLELE; EPIDEMIOLOGY; GENETIC PREDISPOSITION;

ALLELES; EPIDEMIOLOGIC STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK FACTORS;

EID: 77950910251     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph7030711     Document Type: Review

References (67)

1. Vandenbroucke, J.P. When are observational studies as credible as randomised trials? Lancet 2004, 363, 1728-1731.
2. Stampfer, M.J.; Colditz, G.A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev. Med. 1991, 20, 47-63.
3. Rossouw, J.E.; Anderson, G.L.; Prentice, R.L.; LaCroix, A.Z.; Kooperberg, C. Stefanick, M.L.; Jackson, R.D.; Beresford, S.A.; Howard, B.V.; Johnson, K.C.; Kotchen, J.M.; Ockene, J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288, 321-333.
4. Rimm, E.B.; Stampfer, M.J.; Ascherio, A.; Giovannucci, E.; Colditz, G.A.; Willett, W.C. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 1993, 328, 1450-1456.
5. Osganian, S.K.; Stampfer, M.J.; Rimm, E.; Spiegelman, D.; Hu, F.B.; Manson, J.E.; Willett, W.C. Vitamin C and risk of coronary heart disease in women. J. Am. Coll. Cardiol. 2003, 42, 246-252.
6. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360, 23-33.
7. Ebrahim, S.; Davey, S.G. Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum. Genet. 2008, 123, 15-33.
8. Davey, S.G.; Ebrahim, S. Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int. J. Epidemiol. 2003, 32, 1-22.
9. Lewis, S.J.; Smith, G.D. Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 1967-1971.
10. Boccia, S.; Hashibe, M.; Galli, P.; De, F.E.; Asakage, T.; Hashimoto, T.; Hiraki, A.; Katoh, T.; Nomura, T.; Yokoyama, A.; van Duijn, C.M.; Ricciardi, G.; Boffetta P. Aldehyde dehydrogenase 2 and head and neck cancer: a meta-analysis implementing a Mendelian randomization approach. Cancer Epidemiol. Biomarkers Prev. 2009, 18, 248-254.
11. Katan, M.B. Apolipoprotein E isoforms, serum cholesterol, and cancer. Lancet 1986, 1, 507-508.
12. Davey, S.G.; Leary, S.; Ness, A.; Lawlor, D.A. Challenges and novel approaches in the epidemiological study of early life influences on later disease. Adv. Exp. Med. Biol. 2009, 646, 1-14.
13. Lawlor, D.A.; Harbord, R.M.; Sterne, J.A.; Timpson, N.; Davey, S.G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat. Med. 2008, 27, 1133-1163.
14. Thomas, D.C.; Conti, D.V. Commentary: the concept of 'Mendelian Randomization'. Int. J. Epidemiol. 2004, 33, 21-25.
15. Wehby, G.L.; Ohsfeldt, R.L.; Murray, J.C. 'Mendelian randomization' equals instrumental variable analysis with genetic instruments. Stat. Med. 2008, 27, 2745-2749.
16. Greenland, S.; Pearl, J.; Robins, J.M. Causal diagrams for epidemiologic research. Epidemiology 1999, 10, 37-48.
17. Nelson, C.R.; Startz, R. The distribution of the instrumental variables estimator and its t-ratio when the instrument is a poor one. J. Busin. 1990, 63, S125-S140.
18. Stock, J.H.; Wright, J.H.; Yogo, M. A survey of weak instruments and weak identification in generalized method of moments. J. Econ. Statist. 2002, 4, 518-529.
19. Firmann, M.; Mayor, V.; Vidal, P.M.; Bochud, M.; Pecoud, A.; Hayoz, D.; Paccaud, F.; Preisig, M.; Song, K.S.; Yuan, X.; Danoff, T.M.; Stirnadel, H.A.; Waterworth, D.; Mooser, V.; Waeber, G.; Vollenweider, P. The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc. Disord. 2008, 8, 6.
20. Perry, J.R.; Weedon, M.N.; Langenberg, C.; Jackson, A.U.; Lyssenko, V.; Sparso, T.; Thorleifsson, G.; Grallert, H.; Ferrucci, L.; Maggio, M.; Paolisso, G.; Walker, M.; Palmer, C.N.; Payne, F.; Young, E.; Herder, C.; Narisu, N.; Morken, M.A.; Bonnycastle, L.L.; Owen, K.R.; Shields, B.; Knight, B.; Bennett, A.; Groves, C.J.; Ruokonen, A.; Jarvelin, M.R.; Pearson, E.; Pascoe, L.; Ferrannini, E.; Bornstein, S.R.; Stringham, H.M.; Scott, L.J.; Kuusisto, J.; Nilsson, P.; Neptin, M.; Gjesing, A.P.; Pisinger, C; Lauritzen, T; Sandbaek, A; Sampson, M; Zeggini, E.; Lindgren, C.M.; Steinthorsdottir, V.; Thorsteinsdottir, U.; Hansen, T.; Schwarz, P.; Illig, T.; Laakso, M.; Stefansson, K.; Morris, A.D.; Groop, L.; Pedersen, O.; Boehnke, M.; Barroso, I.; Wareham, N.J.; Hattersley, A.T.; McCarthy, M.I.; Frayling, T.M. Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum. Mol. Genet. 2010, 19, 535-544.
21. Ding, E.L.; Song, Y.; Manson, J.E.; Hunter, D.J.; Lee, C.C.; Rifai, N.; Buring, J.E.; Gaziano, J.M.; Liu, S. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N. Engl. J. Med. 2009, 361, 1152-1163.
22. Perry, J.R.; Ferrucci, L.; Bandinelli, S.; Guralnik, J.; Semba, R.D.; Rice, N., Melzer, D.; Saxena, R.; Scott, L.J.; McCarthy, M.I.; Hattersley, A.T.; Zeggini, E.; Weedon, M.N.; Frayling, T.M. Circulating beta-carotene levels and type 2 diabetes-cause or effect? Diabetologia 2009, 52, 2117-2121.
23. Herder, C.; Klopp, N.; Baumert, J.; Muller, M.; Khuseyinova, N.; Meisinger, C.; Martin, S.; Illig, T.; Koenig, W.; Thorand, B. Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002. Diabetologia 2008, 51, 276-284.
24. Linsel-Nitschke, P.; Gotz, A.; Erdmann, J.; Braenne, I.; Braund, P.; Hengstenberg, C.; Stark, K.; Fischer, M.; Schreiber, S.; El Mokhtari, N.E.; Schaefer, A.; Schrezenmeir, J.; Rubin, D.; Hinney, A.; Reinehr, T.; Roth, C.; Ortlepp, J.; Hanrath, P.; Hall, A.S.; Mangino, M.; Lieb, W.; Lamina, C.; Heid, I.M.; Doering, A.; Gieger, C.; Peters, A.; Meitinger, T.; Wichmann, H.E.; Konig, I.R.; Ziegler, A.; Kronenberg, F.; Samani, N.J.; Schunkert, H. Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease--a Mendelian Randomisation study. PLoS One 2008, 3, e2986.
25. Cohen, J.C.; Boerwinkle, E.; Mosley, T.H., Jr.; Hobbs, H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 2006, 354, 1264-1272.
26. Lawlor, D.A.; Harbord, R.M.; Timpson, N.J.; Lowe, G.D.; Rumley, A.; Gaunt, T.R.; Baker, I.; Yarnell, J.W.; Kivimaki, M.; Kumari, M.; Norman, P.E.; Jamrozik, K.; Hankey, G.J.; Almeida, O.P.; Flicker, L.; Warrington, N.; Marmot, M.G.; Ben-Shlomo, Y.; Palmer, L.J.; Day, I.N.; Ebrahim, S.; Smith, G.D. The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participants. PLoS.One. 2008, 3, e3011.
27. Elliott, P.; Chambers, J.C.; Zhang, W.; Clarke, R.; Hopewell, J.C.; Peden, J.F.; Erdmann, J.; Braund, P.; Engert, J.C.; Bennett, D.; Coin, L.; Ashby, D.; Tzoulaki, I.; Brown, I.J.; Mt-Isa, S.; McCarthy, M.I.; Peltonen, L.; Freimer, N.B.; Farrall, M.; Ruokonen, A.; Hamsten, A.; Lim, N.; Froguel, P.; Waterworth, D.M.; Vollenweider, P.; Waeber, G.; Jarvelin, M.R.; Mooser, V.; Scott, J.; Hall, A.S.; Schunkert, H.; Anand, S.S.; Collins, R.; Samani, N.J.; Watkins, H.; Kooner, J.S. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009, 302, 37-48.
28. Casas, J.P.; Shah, T.; Cooper, J.; Hawe, E.; McMahon, A.D.; Gaffney, D.; Packard, C.J.; O'Reilly, D.S.; Juhan-Vague, I.; Yudkin, J.S.; Tremoli, E.; Margaglione, M.; Di, M.G.; Hamsten, A.; Kooistra, T.; Stephens, J.W.; Hurel, S.J.; Livingstone, S.; Colhoun, H.M.; Miller, G.J.; Bautista, L.E.; Meade, T.; Sattar, N.; Humphries, S.E.; Hingorani, A.D. Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int. J. Epidemiol. 2006, 35, 922-931.
29. Kamstrup, P.R.; Tybjaerg-Hansen, A.; Steffensen, R.; Nordestgaard, B.G. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009, 301, 2331-2339.
30. Keavney, B.; Danesh, J.; Parish, S.; Palmer, A.; Clark, S.; Youngman, L.; Delepine, M.; Lathrop, M.; Peto, R.; Collins, R. Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'. Int. J. Epidemiol. 2006, 35, 935-943.
31. Casas, J.P.; Bautista, L.E.; Smeeth, L.; Sharma, P.; Hingorani, A.D. Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet 2005, 365, 224-232.
32. Davey, S.G.; Lawlor, D.A.; Harbord, R.; Timpson, N.; Rumley, A.; Lowe, G.D.; Day, I.N.; Ebrahim, S. Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 1051-1056.
33. Almon, R.; Alvarez-Leon, E.E.; Engfeldt, P.; Serra-Majem, L.; Magnuson, A.; Nilsson, T.K. Associations between lactase persistence and the metabolic syndrome in a cross-sectional study in the Canary Islands. Eur. J. Nutr. 2009, in press.
34. Wu, Y.; Li, H.; Loos, R.J.; Qi, Q.; Hu, F.B.; Liu, Y.; Lin, X. RBP4 variants are significantly associated with plasma RBP4 levels and hypertriglyceridemia risk in Chinese Hans. J. Lipid Res. 2009, 50, 1479-1486.
35. Trompet, S.; Jukema, J.W.; Katan, M.B.; Blauw, G.J.; Sattar, N.; Buckley, B.; Caslake, M.; Ford, I.; Shepherd, J.; Westendorp, R.G.; de Craen, A.J. Apolipoprotein e genotype, plasma cholesterol, and cancer: a Mendelian randomization study. Am. J. Epidemiol. 2009, 170, 1415-1421.
36. Brennan, P.; McKay, J.; Moore, L.; Zaridze, D.; Mukeria, A.; Szeszenia-Dabrowska, N.; Lissowska, J.; Rudnai, P.; Fabianova, E.; Mates, D.; Bencko, V.; Foretova, L.; Janout, V.; Chow, W.H.; Rothman, N.; Chabrier, A.; Gaborieau, V.; Timpson, N.; Hung, R.J.; Smith, G.D. Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype. Int. J. Epidemiol. 2009, 38, 971-975.
37. Ioannidis, A.; Ikonomi, E.; Dimou, N.L.; Douma, L.; Bagos, P.G. Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: A Mendelian randomization meta-analysis. Mol. Genet. Metab. 2009, in press.
38. Rice, N.E.; Bandinelli, S.; Corsi, A.M.; Ferrucci, L.; Guralnik, J.M.; Miller, M.A.; Kumari, M.; Murray, A.; Frayling, T.M.; Melzer, D. The paraoxonase (PON1) Q192R polymorphism is not associated with poor health status or depression in the ELSA or INCHIANTI studies. Int. J. Epidemiol. 2009, 38, 1374-1379.
39. Bech, B.H.; Autrup, H.; Nohr, E.A.; Henriksen, T.B.; Olsen, J. Stillbirth and slow metabolizers of caffeine: comparison by genotypes. Int. J. Epidemiol. 2006, 35, 948-953.
40. Lim, L.S.; Tai, E.S.; Aung, T.; Tay, W.T.; Saw, S.M.; Seielstad, M.; Wong, T.Y. Relation of age-related cataract with obesity and obesity genes in an Asian population. Am. J. Epidemiol. 2009, 169, 1267-1274.
41. Freathy, R.M.; Timpson, N.J.; Lawlor, D.A.; Pouta, A.; Ben-Shlomo, Y.; Ruokonen, A.; Ebrahim, S.; Shields, B.; Zeggini, E.; Weedon, M.N.; Lindgren, C.M.; Lango, H.; Melzer, D.; Ferrucci, L.; Paolisso, G.; Neville, M.J.; Karpe, F.; Palmer, C.N.; Morris, A.D.; Elliott, P.; Jarvelin, M.R.; Smith, G.D.; McCarthy, M.I.; Hattersley, A.T.; Frayling, T.M. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes 2008, 57, 1419-1426.
42. Welsh, P.; Polisecki, E.; Robertson, M.; Jahn, S.; Buckley, B.M.; de Craen, A.J.; Ford, I.; Jukema, J.W.; Macfarlane, P.W.; Packard, C.J.; Stott, D.J.; Westendorp, R.G.; Shepherd, J.; Hingorani, A.D.; Smith, G.D.; Schaefer, E.; Sattar, N. Unraveling the Directional Link between Adiposity and Inflammation: A Bidirectional Mendelian Randomization Approach. J. Clin. Endocrinol. Metab 2009, doi:10.1210/jc.2009-1064.
43. Bochud, M.; Marquant, F.; Marques-Vidal, P.M.; Vollenweider, P.; Beckmann, J.S.; Mooser, V.; Paccaud, F.; Rousson, V. Association between C-reactive protein and adiposity in women. J. Clin. Endocrinol. Metab. 2009, 94, 3969-3977.
44. Timpson, N.J.; Lawlor, D.A.; Harbord, R.M.; Gaunt, T.R.; Day, I.N.; Palmer, L.J.; Hattersley, A.T.; Ebrahim, S.; Lowe, G.D.; Rumley, A.; Davey, S.G. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 2005, 366, 1954-1959.
45. Timpson, N.J.; Harbord, R.; Davey, S.G.; Zacho, J.; Tybjaerg-Hansen, A.; Nordestgaard, B.G. Does greater adiposity increase blood pressure and hypertension risk?: Mendelian randomization using the FTO/MC4R genotype. Hypertension 2009, 54, 84-90.
46. Timpson, N.J.; Sayers, A.; Davey-Smith, G.; Tobias, J.H. How does body fat influence bone mass in childhood? A Mendelian randomization approach. J. Bone Miner. Res. 2009, 24, 522-533.
47. Obermayer-Pietsch, B.M.; Bonelli, C.M.; Walter, D.E.; Kuhn, R.J.; Fahrleitner-Pammer, A.; Berghold, A.; Goessler, W.; Stepan, V.; Dobnig, H.; Leb, G.; Renner, W. Genetic predisposition for adult lactose intolerance and relation to diet, bone density, and bone fractures. J. Bone Miner Res. 2004, 19, 42-47.
48. Brunner, E.J.; Kivimaki, M.; Witte, D.R.; Lawlor, D.A.; Davey, S.G.; Cooper, J.A.; Miller, M.; Lowe, G.D.; Rumley, A.; Casas, J.P.; Shah, T.; Humphries, S.E.; Hingorani, A.D.; Marmot, M.G.; Timpson, N.J.; Kumari, M. Inflammation, insulin resistance, and diabetes-Mendelian randomization using CRP haplotypes points upstream. PLoS. Med. 2008, 5, e155.
49. Kivimaki, M.; Lawlor, D.A.; Smith, G.D.; Kumari, M.; Donald, A.; Britton, A.; Casas, J.P.; Shah, T.; Brunner, E.; Timpson, N.J.; Halcox, J.P.; Miller, M.A.; Humphries, S.E.; Deanfield, J.; Marmot, M.G.; Hingorani, A.D. Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study. PLoS.One. 2008, 3, e3013.
50. Kivimaki, M.; Lawlor, D.A.; Eklund, C.; Smith, G.D.; Hurme, M.; Lehtimaki, T.; Viikari, J.S.; Raitakari, O.T. Mendelian randomization suggests no causal association between C-reactive protein and carotid intima-media thickness in the young Finns study. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 978-979.
51. Kivimaki, M.; Smith, G.D.; Timpson, N.J.; Lawlor, D.A.; Batty, G.D.; Kahonen, M.; Juonala, M.; Ronnemaa, T.; Viikari, J.S.; Lehtimaki, T.; Raitakari, O.T. Lifetime body mass index and later atherosclerosis risk in young adults: examining causal links using Mendelian randomization in the Cardiovascular Risk in Young Finns study. Eur. Heart J. 2008, 29, 2552-2560.
52. Viikari, L.A.; Huupponen, R.K.; Viikari, J.S.; Marniemi, J.; Eklund, C.; Hurme, M.; Lehtimaki, T.; Kivimaki, M.; Raitakari, O.T. Relationship between leptin and C-reactive protein in young Finnish adults. J. Clin. Endocrinol. Metab 2007, 92, 4753-4758.
53. Sunyer, J.; Pistelli, R.; Plana, E.; Andreani, M.; Baldari, F.; Kolz, M.; Koenig, W.; Pekkanen, J.; Peters, A.; Forastiere F. Systemic inflammation, genetic susceptibility and lung function. Eur. Respir. J. 2008, 32, 92-97.
54. Frayling, T.M.; Rafiq, S.; Murray, A.; Hurst, A.J.; Weedon, M.N.; Henley, W.; Bandinelli, S.; Corsi, A.M.; Ferrucci, L.; Guralnik, J.M.; Wallace, R.B.; Melzer, D. An interleukin-18 polymorphism is associated with reduced serum concentrations and better physical functioning in older people. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62, 73-78.
55. Bochud, M.; Chiolero, A.; Elston, R.C.; Paccaud, F. A cautionary note on the use of Mendelian randomization to infer causation in observational epidemiology. Int. J. Epidemiol. 2008, 37, 414-416.
56. Smith, G.D.; Ebrahim, S. Mendelian randomization: prospects, potentials, and limitations. Int. J. Epidemiol. 2004, 33, 30-42.
57. Greenland, S. An introduction to instrumental variables for epidemiologists. Int. J. Epidemiol. 2000, 29, 722-729.
58. Didelez, V.; Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat. Methods Med. Res. 2007, 16, 309-330.
59. Zollner, S.; Wen, X.; Hanchard, N.A.; Herbert, M.A.; Ober, C.; Pritchard, J.K. Evidence for extensive transmission distortion in the human genome. Am. J. Hum. Genet. 2004, 74, 62-72.
60. Isotalo, P.A.; Wells, G.A.; Donnelly, J.G. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am. J. Hum. Genet. 2000, 67, 986-990.
61. Zetterberg, H.; Regland, B.; Palmer, M.; Ricksten, A.; Palmqvist, L.; Rymo, L.; Arvanitis, D.A.; Spandidos, D.A.; Blennow, K. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur. J. Hum. Genet. 2002, 10, 113-118.
62. Minelli, C.; Thompson, J.R.; Tobin, M.D.; Abrams, K.R. An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization. Am. J. Epidemiol. 2004, 160, 445-452.
63. Thompson, J.R.; Minelli, C.; Abrams, K.R.; Tobin, M.D.; Riley, R.D. Meta-analysis of genetic studies using Mendelian randomization--a multivariate approach. Stat. Med. 2005, 24, 2241-2254.
64. Thomas, D.C.; Lawlor, D.A.; Thompson, J.R. Re: Estimation of bias in nongenetic observational studies using Mendelian triangulation by Bautista et al.. Ann. Epidemiol. 2007, 17, 511-513.
65. Robins, J.; Rotnitzky, A. Estimation of treatment effects in randomised trials with non-compliance and a dichotomous outcome using structural mean models. Biometrika 2004, 90, 763-783.
66. Vansteelandt, S.; Goetghebeur, S. Causal inference with generalized structural mean models. J. Royal Statist. Soc. Series B (Statistical Methodology) 2003, 65, 817-835.
67. Palmer, T.M.; Thompson, J.R.; Tobin, M.D.; Sheehan, N.A.; Burton, P.R. Adjusting for bias and unmeasured confounding in Mendelian randomization studies with binary responses. Int. J. Epidemiol. 2008, 37, 1161-1168.